CLASSYS Inc. (KOSDAQ:214150)
47,300
-200 (-0.42%)
Nov 5, 2025, 3:30 PM KST
CLASSYS Market Cap
CLASSYS has a market cap or net worth of 3.1 trillion as of November 5, 2025. Its market cap has decreased by -16.69% in one year.
Market Cap
3.10T
Enterprise Value
3.02T
Revenue
294.21B
Ranking
n/a
PE Ratio
42.62
Stock Price
47,300.00
Market Cap Chart
Since December 13, 2017, CLASSYS's market cap has increased from 279.08B to 3.10T, an increase of 1,009.97%. That is a compound annual growth rate of 35.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 3.10T | -0.76% |
| Dec 30, 2024 | 3.12T | 28.96% |
| Dec 28, 2023 | 2.42T | 104.22% |
| Dec 29, 2022 | 1.19T | -2.59% |
| Dec 30, 2021 | 1.22T | 22.09% |
| Dec 30, 2020 | 996.52B | 9.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.46T |
| ALTEOGEN | 27.97T |
| SK Biopharmaceuticals | 9.30T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.19T |
| Peptron | 6.14T |
| ABL Bio | 5.69T |